Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma.
H
H
Tilly
F
F
Morschhauser
G
G
Salles
R-O
RO
Casasnovas
P
P
Feugier
T J
TJ
Molina
F
F
Jardin
L
L
Terriou
C
C
Haioun
B
B
Coiffier
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male